Samra Turajlić, Group Leader at Cancer Research UK Manchester Institute, shared Fondazione Pezcoller’s post on LinkedIn, adding:
“Thank you Fondazione Pezcoller and UniTrento CIBIO for the exceptionally warm welcome and extraordinary hospitality!
I am deeply honored to become part of the Pezcoller family. This award is especially meaningful to me because it honors the legacy of Alessio Pezcoller, a surgeon. Surgeons have been critical collaborators throughout our programme, and I remain in awe of their commitment to their patients, cancer research and care.
And a very special thank you to Enzo Galligioni whose passion and energy are simply unparalleled! I particularly value our shared belief that true excellence must go hand in hand with humanity and kindness (and some truly excellent pasta).”
Fondazione Pezcoller shared:
“World-class cancer research takes center stage in Trento!
We were honored to host Prof. Samra Turajlić from Cancer Research UK (CRUK), winner of the 2026 Pezcoller Foundation-European Association for Cancer Research (EACR) Translational Cancer Researcher Award, a prestigious recognition to scientists who are pioneering new frontiers in translational cancer research.
It was an extraordinary day (and evening!), from her highly anticipated keynote lecture at UniTrento CIBIO to inspiring informal discussions, where we experienced firsthand both her exceptional scientific talent and her profound passion for research.
Prof. Turajlic is revolutionizing our understanding of cancer evolution, with a particular focus on melanoma and renal cell carcinoma.
Leveraging cutting-edge genomics, her work decrypts how tumor cells mutate over time and adapt to evade therapies, paving the way for increasingly targeted and personalized treatments.
Discover more about her breakthrough research.”
This can be interesting:
Samra Turajlić: A Pleasure to Co-Chair the Biology and Models of Early Cancer Session at EDXCONF26
